- Home
- TSBK vs LRMR Comparison
TSBK vs LRMR Comparison
Compare TSBK & LRMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSBK
- LRMR
- Stock Information
- Founded
- TSBK 1915
- LRMR N/A
- Country
- TSBK United States
- LRMR United States
- Employees
- TSBK N/A
- LRMR N/A
- Industry
- TSBK Banks
- LRMR Biotechnology: Pharmaceutical Preparations
- Sector
- TSBK Finance
- LRMR Health Care
- Exchange
- TSBK Nasdaq
- LRMR Nasdaq
- Market Cap
- TSBK 251.1M
- LRMR 204.9M
- IPO Year
- TSBK 1998
- LRMR N/A
- Fundamental
- Price
- TSBK $32.35
- LRMR $3.27
- Analyst Decision
- TSBK
- LRMR Strong Buy
- Analyst Count
- TSBK 0
- LRMR 7
- Target Price
- TSBK N/A
- LRMR $17.86
- AVG Volume (30 Days)
- TSBK 12.2K
- LRMR 1.1M
- Earning Date
- TSBK 07-22-2025
- LRMR 08-06-2025
- Dividend Yield
- TSBK 3.27%
- LRMR N/A
- EPS Growth
- TSBK 6.24
- LRMR N/A
- EPS
- TSBK 3.25
- LRMR N/A
- Revenue
- TSBK $76,813,000.00
- LRMR N/A
- Revenue This Year
- TSBK N/A
- LRMR N/A
- Revenue Next Year
- TSBK N/A
- LRMR N/A
- P/E Ratio
- TSBK $10.06
- LRMR N/A
- Revenue Growth
- TSBK 2.71
- LRMR N/A
- 52 Week Low
- TSBK $26.09
- LRMR $1.61
- 52 Week High
- TSBK $33.98
- LRMR $11.20
- Technical
- Relative Strength Index (RSI)
- TSBK 61.25
- LRMR 64.72
- Support Level
- TSBK $31.24
- LRMR $3.30
- Resistance Level
- TSBK $32.42
- LRMR $3.68
- Average True Range (ATR)
- TSBK 0.71
- LRMR 0.25
- MACD
- TSBK 0.11
- LRMR 0.02
- Stochastic Oscillator
- TSBK 100.00
- LRMR 72.41
About TSBK Timberland Bancorp Inc.
Timberland Bancorp Inc is a bank holding company. It has one reportable operating segment which is defined as community banking in western Washington under the operating name Timberland Bank. The bank offers a variety of services such as checking accounts, online and mobile banking, savings accounts, home loans, consumer loans, construction loans, business rewards, cash management, small business solutions, and business checking accounts among others. It also offers loans to real estate, including residential and commercial, multi-family construction loans, one- to four-family residential loans, multi-family loans, commercial real estate loans, and land loans.
About LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.